Amanote Research
Register
Sign In
Therapeutic Apheresis: Why?
Therapeutic Apheresis and Dialysis
- United Kingdom
doi 10.1111/1744-9987.12353
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hematology
Nephrology
Date
October 1, 2015
Authors
Paul S. Malchesky
Publisher
Wiley
Related search
Aging, Disease, and Therapeutic Apheresis
Therapeutic Apheresis and Dialysis
Hematology
Nephrology
Therapeutic Apheresis in Dermatological Diseases
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
Therapeutic Apheresis: A Single Center Experience
The Journal of Tepecik Education and Research Hospital
Applications of Therapeutic Apheresis in Patients With Malignant Disease
Oncologist
Cancer Research
Medicine
Oncology
Lipoprotein Apheresis Is an Optimal Therapeutic Option to Reduce Increased Lp(a) Levels
Clinical Research in Cardiology Supplements
Nuclear Medicine
Radiology
Molecular Biology
Structural Biology
Imaging
Medicine
LDL-Apheresis: Technical and Clinical Aspects
The Scientific World Journal
Biochemistry
Medicine
Genetics
Molecular Biology
Environmental Science
Why Targeting HDL Should Work as a Therapeutic Tool, but Has Not
Journal of Cardiovascular Pharmacology
Cardiovascular Medicine
Pharmacology
Cardiology
Lipoprotein Apheresis Efficacy, Challenges and Outcomes: A Descriptive Analysis From the UK Lipoprotein Apheresis Registry, 1989–2017
Atherosclerosis
Cardiovascular Medicine
Cardiology
Extended Storage of Autologous Apheresis Platelets in Plasma
Vox Sanguinis
Medicine
Hematology